FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101469 [Registered on: 19/01/2026] Trial Registered Prospectively
Last Modified On: 17/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Relationship Between Eye Surface Health and Nerve Problems in People with Type 2 Diabets 
Scientific Title of Study   Correlating Peripheral Neuropathy Symptoms with Ocular Surface Parameters in Type 2 Diabetes Mellitus 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
not applicable  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Simran 
Designation  Optometrist 
Affiliation  Centre For Sight Eye Hospital 
Address  Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi - 110077
Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi - 110077
West
DELHI
110077
India 
Phone  7838871921  
Fax    
Email  sgalhotra71.sg@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Roshani Sen Gupta 
Designation  Assistant Professor 
Affiliation  GD Goenka University 
Address  GD Goenka Educational City, Sohna-Gurgon Rd,Sohna,Sohna Rural, Haryana 122103
GD Goenka Educational City, Sohna-Gurgon Rd,Sohna,Sohna Rural, Haryana 122103
Gurgaon
HARYANA
122103
India 
Phone  7980632247  
Fax    
Email  roshani.sengupta@gdgu.org  
 
Details of Contact Person
Public Query
 
Name  Simran 
Designation  Optometrist 
Affiliation  Centre For Sight Eye Hospital 
Address  Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi
Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi
New Delhi
DELHI
110077
India 
Phone  7838871921  
Fax    
Email  sgalhotra71.sg@gmail.com  
 
Source of Monetary or Material Support  
Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi, Delhi -110077 , Provided infrastructure and routine clinical facilities 
 
Primary Sponsor  
Name  Centre For Sight Eye Hospital 
Address  Plot no 9, Dwarka sector 9, Dwarka , New Delhi 110077 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Simran  Centre For Sight Eye Hospital  Centre For Sight Eye Hospital, Plot No 9,Ophthalmology Department, Optom Room No 1, Diagnostic 1, Dwarka Sector 9, Dwarka, New Delhi - 110077
West
DELHI 
07838871921

sgalhotra71.sg@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Centre For Sight Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Diabetes Mellitus Type 2 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  adults aged 30 to 70 years clinically diagnosed cases of type 2 diabetes mellitus
duration of diabetes greater than or equal to 1 year
patients attending the outpatient department who are clinically stable at the time of examination
willingness to participate and provide written informed consent
ability to undergo
michigan neuropathy screening instrument
ocular surface disease index questionnaire
tear function testing and non invasive ocular surface analyzer evaluation
 
 
ExclusionCriteria 
Details  History of ocular surgery, laser procedures, or significant ocular trauma
Current contact lens wearers
Presence of active ocular infection or inflammation
Diagnosed autoimmune or connective tissue disorders known to affect the ocular surface
Systemic neurological conditions or neuropathies other than diabetic neuropathy
Use of topical ocular medications (other than preservative-free lubricants)
Patients with ocular pathology that may confound ocular surface assessment
Pregnant or lactating women
Individuals unable to cooperate with study procedures or questionnaires 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Correlation Between Peripheral Neuropathy Severity, Assessed Using MNSI Score And Ocular Surface Disease severity, Assessed Using OSDI Score, Schirmer’s Test Values, And Ocular Surface Analyzer Parameters in Patients With Type 2 Diabetes Mellitus.  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison Of Ocular Surface Parameters Between Diabetic Patients With And Without Peripheral Neuropathy.
Assessment Of Symptom–sign Dissociation Between OSDI Scores And Objective Ocular Surface Measurements.
Evaluation Of The Relationship Between Duration Of Diabetes And Ocular Surface Changes.
 
1 year 
 
Target Sample Size   Total Sample Size="95"
Sample Size from India="95" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

After obtaining written informed consent, participants will be evaluated in the following standardized sequence

Screening for dry eye disease through Schirmer’s test in clinical evaluation.

Assessment of peripheral neuropathy using the Michigan Neuropathy Screening Instrument (MNSI) questionnaire

Objective evaluation of ocular surface parameters using an Ocular Surface Analyzer (OSA)

Assessment of dry eye symptoms using the Ocular Surface Disease Index (OSDI) questionnaire

All assessments will be performed by a trained examiner to ensure uniformity and minimize bias.

 
Close